Modulation of antioxidant defense system by the environmental fungicide carbendazim in Leydig cells of rats

• Published in: Reproductive toxicology (Elmsford, N.Y.) N.Y.), 2007-11, Vol.24 (3), p.371-380
• Main Authors: Rajeswary, Sivasankaran, Kumaran, Bassouvalingam, Ilangovan, Ramachandran, Yuvaraj, Sambandam, Sridhar, Muthusami, Venkataraman, Prabhu, Srinivasan, Narasimhan, Aruldhas, Maria Michael
• Format: Article
• Language: English
• Subjects: 17-Hydroxysteroid Dehydrogenases - metabolism; 3-Hydroxysteroid Dehydrogenases - metabolism; Administration, Oral; Air Pollutants, Occupational - toxicity; Animals; Antioxidant enzymes; Antioxidants - metabolism; Benzimidazoles - toxicity; Biological and medical sciences; Carbamates - toxicity; Carbendazim; Drug Administration Schedule; Embryology: invertebrates and vertebrates. Teratology; Estradiol - blood; Fundamental and applied biological sciences. Psychology; Fungicides, Industrial - toxicity; Leydig cells; Leydig Cells - drug effects; Leydig Cells - enzymology; Leydig Cells - pathology; Lipid Peroxidation - drug effects; Male; Medical sciences; Organ Size - drug effects; Oxidative Stress - drug effects; Peroxidases - metabolism; Pesticides, fertilizers and other agrochemicals toxicology; Rats; Rats, Wistar; Reactive oxygen species; Reactive Oxygen Species - metabolism; Recovery of Function; Steroidogenic enzymes; Teratology. Teratogens; Testis - drug effects; Testis - metabolism; Testis - pathology; Testosterone - blood; Toxicology
• ISSN: 0890-6238; 1873-1708
• DOI: 10.1016/j.reprotox.2007.03.010

Carbendazim (methyl-2-benzimidazole carbamate, MBC) a metabolite of benomyl is one of the most widespread environmental contaminant of major concern to human and animal reproductive health. The present investigation was undertaken to study the impact of carbendazim exposure on Leydig cell functions. Adult albino male rats of the Wistar strain were administered with carbendazim (25 mg/(kg (body weight)/day)) orally for 48 days. The control animals received vehicle (corn oil) alone. Another group of rats were treated with carbendazim and the same was withdrawn for a further period of 48 days. After the treatment period, rats were euthanized and blood was collected for the assay of serum hormones such as luteinizing hormone (LH), prolactin (PRL), testosterone and estradiol. Testes were immediately removed and Leydig cells were isolated in aseptic condition. Purified Leydig cells were used for quantification of steroidogenic enzymes such as 3β-hydroxysteroid dehydrogenase (3β-HSD) and 17β-hydroxysteroid dehydrogenase (17β-HSD). Leydig cellular enzymatic antioxidants superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), glutathione- S-transferase (GST), γ-glutamyl transpeptidase (γ-GT), glucose-6-phosphate dehydrogenase (G6PDH) and non-enzymatic antioxidants such as reduced glutathione (GSH), α-tocopherol (vitamin E), ascorbic acid (vitamin C) and β-carotene (vitamin A) were assayed. Lipid peroxidation (LPO) and reactive oxygen species (ROS) were also quantified. Carbendazim exposure had no effect on body weight, serum LH and prolactin. However, testis weight, serum testosterone and estradiol were significantly decreased. In addition to this, Leydig cellular activities of steroidogenic enzymes such as 3β-HSD, 17β-HSD, antioxidant enzymes SOD, CAT, GPx, GR, GST, γ-GT, G-6-PDH and non-enzymatic antioxidants such as GSH, vitamins E, C and A were significantly diminished, whereas LPO and ROS were markedly elevated. All these above-mentioned parameters from the animals after withdrawal of MBC treatment were similar to those of the control group. Thus, the present study suggests that chronic low dose treatment of MBC is capable of inducing reproductive toxicity through increased oxidative stress, but is transient and reversible upon withdrawal of treatment.